These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27465994)

  • 41. Abatacept Decreases Renal T-cell Infiltration and Renal Inflammation and Ameliorates Progressive Renal Injury in Obese Dahl Salt-sensitive Rats Before Puberty.
    Ekperikpe US; Mandal S; Bhopatkar AA; Shields CA; Coley CA; Chambers CL; Johnson TD; Cornelius DC; Williams JM
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):635-645. PubMed ID: 38547515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
    Wang C; Li Q; Zhen J; Xu Y; Sun S
    Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.
    Di Lullo L; Gorini A; Russo D; Santoboni A; Ronco C
    Cardiorenal Med; 2015 Oct; 5(4):254-66. PubMed ID: 26648942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early markers of obesity-related renal injury in childhood.
    Ding W; Mak RH
    Pediatr Nephrol; 2015 Jan; 30(1):1-4. PubMed ID: 25322907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.
    Jin C; Jeon Y; Kleven DT; Pollock JS; White JJ; Pollock DM
    J Pharmacol Exp Ther; 2014 Nov; 351(2):467-73. PubMed ID: 25189702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats.
    Ge Y; Murphy SR; Fan F; Williams JM; Falck JR; Liu R; Roman RJ
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F509-15. PubMed ID: 25007877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity and type 2 diabetes in children: epidemiology and treatment.
    Pulgaron ER; Delamater AM
    Curr Diab Rep; 2014 Aug; 14(8):508. PubMed ID: 24919749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous characterization of metabolic, cardiac, vascular and renal phenotypes of lean and obese SHHF rats.
    Youcef G; Olivier A; L'Huillier CP; Labat C; Fay R; Tabcheh L; Toupance S; Rodriguez-Guéant RM; Bergerot D; Jaisser F; Lacolley P; Zannad F; Laurent Vallar ; Pizard A
    PLoS One; 2014; 9(5):e96452. PubMed ID: 24831821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive and anti-inflammatory actions of combined azilsartan and chlorthalidone in Dahl salt-sensitive rats on a high-fat, high-salt diet.
    Jin C; O'Boyle S; Kleven DT; Pollock JS; Pollock DM; White JJ
    Clin Exp Pharmacol Physiol; 2014 Aug; 41(8):579-88. PubMed ID: 24798707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycophenolate mofetil prevents high-fat diet-induced hypertension and renal glomerular injury in Dahl SS rats.
    Spradley FT; De Miguel C; Hobbs J; Pollock DM; Pollock JS
    Physiol Rep; 2013 Nov; 1(6):e00137. PubMed ID: 24400139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.
    Zhang Q; Davis KJ; Hoffmann D; Vaidya VS; Brown RP; Goering PL
    Biomark Med; 2014; 8(1):85-94. PubMed ID: 24325231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
    Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Novel Rat Model of Type 2 Diabetes: The Zucker Fatty Diabetes Mellitus ZFDM Rat.
    Yokoi N; Hoshino M; Hidaka S; Yoshida E; Beppu M; Hoshikawa R; Sudo K; Kawada A; Takagi S; Seino S
    J Diabetes Res; 2013; 2013():103731. PubMed ID: 23671847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenously produced 20-HETE modulates myogenic and TGF response in microperfused afferent arterioles.
    Ge Y; Murphy SR; Lu Y; Falck J; Liu R; Roman RJ
    Prostaglandins Other Lipid Mediat; 2013; 102-103():42-8. PubMed ID: 23500064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and kidney disease: potential mechanisms.
    Wickman C; Kramer H
    Semin Nephrol; 2013 Jan; 33(1):14-22. PubMed ID: 23374890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat.
    Hattori T; Murase T; Ohtake M; Inoue T; Tsukamoto H; Takatsu M; Kato Y; Hashimoto K; Murohara T; Nagata K
    Nutr Diabetes; 2011 Jan; 1(1):e1. PubMed ID: 23154293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity.
    Beyer AM; Raffai G; Weinberg B; Fredrich K; Lombard JH
    Hypertension; 2012 Aug; 60(2):404-10. PubMed ID: 22710645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats.
    Williams JM; Fan F; Murphy S; Schreck C; Lazar J; Jacob HJ; Roman RJ
    Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1209-18. PubMed ID: 22442195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.
    Cheng HT; Huang JW; Chiang CK; Yen CJ; Hung KY; Wu KD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1268-76. PubMed ID: 22337909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.
    Daniels A; Linz D; van Bilsen M; Rütten H; Sadowski T; Ruf S; Juretschke HP; Neumann-Haefelin C; Munts C; van der Vusse GJ; van Nieuwenhoven FA
    Eur J Heart Fail; 2012 Feb; 14(2):193-201. PubMed ID: 22253456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.